Effect of Interferon Treatment on Hearing of Patients with Chronic Hepatitis C
2011
Impact of Interferon Treatment on Hearing in Hepatitis C Patients
Sample size: 21
publication
Evidence: moderate
Author Information
Author(s): Hagr Abdulrahman Jamjoom, Dima Sanai, Waleed Al Hamoudi, Ayman A. Abdo, Ahmed Al-Arfaj
Primary Institution: King Saud University
Hypothesis
Does interferon therapy for hepatitis C affect patients' hearing?
Conclusion
Interferon therapy does not significantly impact the hearing thresholds of patients with hepatitis C.
Supporting Evidence
- Patients were treated with standard doses of pegylated interferon and ribavirin.
- Hearing assessments showed no significant differences before, during, or after treatment.
- Most patients completed the treatment without any side effects related to hearing.
Takeaway
The study found that taking interferon for hepatitis C doesn't hurt your hearing.
Methodology
Patients received pegylated interferon and ribavirin, with hearing tests conducted before, during, and after treatment.
Limitations
The study had a small sample size, which may limit the ability to detect uncommon effects.
Participant Demographics
Mean age was 45.7 years, with a male to female ratio of 1.1:1.
Statistical Information
P-Value
P>0.05
Statistical Significance
p>0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website